Pharmacological treatment for older adults with epilepsy and comorbid neurodegenerative disorders. Issue 2 (10th April 2023)

• Record Type: Journal Article
• Authors: O'Dwyer, Rebecca; Foster, Emma; Leppik, Ilo; Kwan, Patrick
• Is Part Of: Current opinion in neurology. Volume 36:Issue 2(2023)
• Page Start: 117
• Page End: 123
• Publication Date: 2023-04-10
• Subjects: antiseizure medications -- electroencephalogram -- epilepsy -- neurodegenerative disorders -- older adults; Neurology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.805
• DOI: 10.1097/WCO.0000000000001143
• Languages: English
• ISSNs: 1473-6551

Abstract

Abstract : Purpose of review: An increased interest in epilepsy in older adults has emerged as the global population ages. The purpose of this article is to review the literature regarding the pharmacological treatment of epilepsy in older adults, highlighting issues specifically pertinent to those living with comorbid neurodegenerative disorders. Recent findings: Although new original research remains sparse, in the last 5 years, there has been a growing number of studies addressing the relationship between epilepsy and neurodegenerative disorders. Accurate diagnosis is incredibly challenging with electroencephalogram findings often requiring circumspect interpretation. Older individuals are often excluded from or under-represented in clinical trials, and there are sparse guidelines offered on the management of these patients, with even less available in reference to those with neurodegenerative comorbidities. Summary: We propose that seizures occurring earlier in the neurodegenerative process should be treated aggressively, with the goal to inhibit neuro-excitotoxicity and the associated neuronal loss. By strategically choosing newer antiseizure medications with less adverse effects and a holistic approach to treatment, a patient's time living independently can be conserved. In addition, we advocate for original, multinational collaborative research efforts.